FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313394519> ?p ?o ?g. }

• W4313394519 abstract "Abstract Background Both hyperuricaemia and hyperlipidaemia are common metabolic diseases that are closely related to each other, and both are independent risk factors for the development of a variety of diseases. HUA combined with hyperlipidaemia increases the risk of nonalcoholic fatty liver disease and coronary heart disease. This study aimed to investigate the relationship between HUA and hyperlipidaemia and study the metabolic pathway changes in patients with HUA associated with hyperlipidaemia using metabolomics. Methods This was a case‒control study. The prevalence of hyperlipidaemia in HUA patients in the physical examination population of Tianjin Union Medical Centre in 2018 was investigated. Metabolomics analysis was performed on 308 HUA patients and 100 normal controls using Orbitrap mass spectrometry. A further metabolomics study of 30 asymptomatic HUA patients, 30 HUA patients with hyperlipidaemia, and 30 age-and sex-matched healthy controls was conducted. Differential metabolites were obtained from the three groups by orthogonal partial least-squares discrimination analysis, and relevant metabolic pathways changes were analysed using MetaboAnalyst 5.0 software. Results The prevalence of hyperlipidaemia in HUA patients was 69.3%. Metabolomic analysis found that compared with the control group, 33 differential metabolites, including arachidonic acid, alanine, aspartate, phenylalanine and tyrosine, were identified in asymptomatic HUA patients. Pathway analysis showed that these changes were mainly related to 3 metabolic pathways, including the alanine, aspartate and glutamate metabolism pathway. Thirty-eight differential metabolites, including linoleic acid, serine, glutamate, and tyrosine, were identified in HUA patients with hyperlipidaemia. Pathway analysis showed that they were mainly related to 7 metabolic pathways, including the linoleic acid metabolism pathway, phenylalanine, tyrosine and tryptophan biosynthesis pathway, and glycine, serine and threonine metabolism pathway. Conclusions Compared to the general population, the HUA population had a higher incidence of hyperlipidaemia. HUA can cause hyperlipidaemia. by affecting the metabolic pathways of linoleic acid metabolism and alanine, aspartate and glutamate metabolism. Fatty liver is closely associated with changes in the biosynthesis pathway of pahenylalanine, tyrosine, and tryptophan in HUA patients with hyperlipidaemia. Changes in the glycine, serine and threonine metabolism pathway in HUA patients with hyperlipidaemia may lead to chronic kidney disease." @default.
• W4313394519 created "2023-01-06" @default.
• W4313394519 creator A5032623957 @default.
• W4313394519 creator A5035339773 @default.
• W4313394519 creator A5040591487 @default.
• W4313394519 creator A5045246728 @default.
• W4313394519 creator A5058488226 @default.
• W4313394519 creator A5064490827 @default.
• W4313394519 creator A5078411482 @default.
• W4313394519 creator A5079460148 @default.
• W4313394519 creator A5080908700 @default.
• W4313394519 creator A5081675173 @default.
• W4313394519 date "2022-12-31" @default.
• W4313394519 modified "2023-10-18" @default.
• W4313394519 title "Metabolic pathway analysis of hyperuricaemia patients with hyperlipidaemia based on high-throughput mass spectrometry: a case‒control study" @default.
• W4313394519 cites W1768572786 @default.
• W4313394519 cites W2162309758 @default.
• W4313394519 cites W2364200298 @default.
• W4313394519 cites W2566013264 @default.
• W4313394519 cites W2597385654 @default.
• W4313394519 cites W2623056842 @default.
• W4313394519 cites W2806746634 @default.
• W4313394519 cites W2809713691 @default.
• W4313394519 cites W2885647614 @default.
• W4313394519 cites W2913879375 @default.
• W4313394519 cites W2936763250 @default.
• W4313394519 cites W2953700346 @default.
• W4313394519 cites W2969664314 @default.
• W4313394519 cites W2970075619 @default.
• W4313394519 cites W2971439746 @default.
• W4313394519 cites W2982684359 @default.
• W4313394519 cites W2992106870 @default.
• W4313394519 cites W3006138011 @default.
• W4313394519 cites W3014057324 @default.
• W4313394519 cites W3014625294 @default.
• W4313394519 cites W3032409420 @default.
• W4313394519 cites W3039969088 @default.
• W4313394519 cites W3041991893 @default.
• W4313394519 cites W3047751352 @default.
• W4313394519 cites W3048011949 @default.
• W4313394519 cites W3093217313 @default.
• W4313394519 cites W3094724625 @default.
• W4313394519 cites W3097332689 @default.
• W4313394519 cites W3127750095 @default.
• W4313394519 cites W3132171162 @default.
• W4313394519 cites W3137957285 @default.
• W4313394519 cites W3168346427 @default.
• W4313394519 cites W3174303215 @default.
• W4313394519 cites W3194632782 @default.
• W4313394519 cites W4230141246 @default.
• W4313394519 doi "https://doi.org/10.1186/s12944-022-01765-0" @default.
• W4313394519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585694" @default.
• W4313394519 hasPublicationYear "2022" @default.
• W4313394519 type Work @default.
• W4313394519 citedByCount "2" @default.
• W4313394519 countsByYear W43133945192023 @default.
• W4313394519 crossrefType "journal-article" @default.
• W4313394519 hasAuthorship W4313394519A5032623957 @default.
• W4313394519 hasAuthorship W4313394519A5035339773 @default.
• W4313394519 hasAuthorship W4313394519A5040591487 @default.
• W4313394519 hasAuthorship W4313394519A5045246728 @default.
• W4313394519 hasAuthorship W4313394519A5058488226 @default.
• W4313394519 hasAuthorship W4313394519A5064490827 @default.
• W4313394519 hasAuthorship W4313394519A5078411482 @default.
• W4313394519 hasAuthorship W4313394519A5079460148 @default.
• W4313394519 hasAuthorship W4313394519A5080908700 @default.
• W4313394519 hasAuthorship W4313394519A5081675173 @default.
• W4313394519 hasBestOaLocation W43133945191 @default.
• W4313394519 hasConcept C126322002 @default.
• W4313394519 hasConcept C134018914 @default.
• W4313394519 hasConcept C192989942 @default.
• W4313394519 hasConcept C21565614 @default.
• W4313394519 hasConcept C2776954865 @default.
• W4313394519 hasConcept C2778772119 @default.
• W4313394519 hasConcept C2779134260 @default.
• W4313394519 hasConcept C60644358 @default.
• W4313394519 hasConcept C62231903 @default.
• W4313394519 hasConcept C71924100 @default.
• W4313394519 hasConcept C86803240 @default.
• W4313394519 hasConceptScore W4313394519C126322002 @default.
• W4313394519 hasConceptScore W4313394519C134018914 @default.
• W4313394519 hasConceptScore W4313394519C192989942 @default.
• W4313394519 hasConceptScore W4313394519C21565614 @default.
• W4313394519 hasConceptScore W4313394519C2776954865 @default.
• W4313394519 hasConceptScore W4313394519C2778772119 @default.
• W4313394519 hasConceptScore W4313394519C2779134260 @default.
• W4313394519 hasConceptScore W4313394519C60644358 @default.
• W4313394519 hasConceptScore W4313394519C62231903 @default.
• W4313394519 hasConceptScore W4313394519C71924100 @default.
• W4313394519 hasConceptScore W4313394519C86803240 @default.
• W4313394519 hasIssue "1" @default.
• W4313394519 hasLocation W43133945191 @default.
• W4313394519 hasLocation W43133945192 @default.
• W4313394519 hasLocation W43133945193 @default.
• W4313394519 hasOpenAccess W4313394519 @default.
• W4313394519 hasPrimaryLocation W43133945191 @default.
• W4313394519 hasRelatedWork W1966504330 @default.
• W4313394519 hasRelatedWork W1973843004 @default.
• W4313394519 hasRelatedWork W1979139803 @default.
• W4313394519 hasRelatedWork W2030889776 @default.

• next